Trevena, Inc. (TRVN) CEO To Present At The 13th Annual Needham Healthcare Conference
4/2/2014 7:06:54 AM
Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Maxine Gowen, Ph.D., its president and chief executive officer, will present at the 13th Annual Needham Healthcare Conference on Tuesday, April 8, 2014 at 2:20 p.m. ET in New York City.
Help employers find you! Check out all the jobs and post your resume.
comments powered by